Sensitivity to vaccines, therapeutic antibodies, and viral entry inhibitors and advances to counter the SARS-CoV-2 Omicron variant
H Zhou, M Møhlenberg, JC Thakor… - Clinical microbiology …, 2022 - Am Soc Microbiol
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) keeps evolving and
mutating into newer variants over time, which gain higher transmissibility, disease severity …
mutating into newer variants over time, which gain higher transmissibility, disease severity …
Advances in nanomaterial-based platforms to combat COVID-19: Diagnostics, preventions, therapeutics, and vaccine developments
The COVID-19 pandemic caused by the SARS-CoV-2, a ribonucleic acid (RNA) virus that
emerged less than two years ago but has caused nearly 6.1 million deaths to date. Recently …
emerged less than two years ago but has caused nearly 6.1 million deaths to date. Recently …
Monkeypox: an extra burden on global health
ARA Saied, AA Metwally… - International journal of …, 2022 - journals.lww.com
Since emergence of the coronavirus disease 2019 (COVID-19) pandemic, caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) in late December 2019, a …
severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) in late December 2019, a …
Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
A Xu, B Hong, F Lou, S Wang, W Li, A Shafqat… - MedComm, 2022 - Wiley Online Library
Since the start of the coronavirus disease 2019 (COVID‐19) pandemic, new variants of
severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) have emerged …
severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) have emerged …
Emergence of Omicron sub-variant BA. 2: Is it a matter of concern amid the COVID-19 pandemic?
M Dhawan, OP Choudhary - International Journal of Surgery, 2022 - journals.lww.com
The appearance of the SARS-CoV-2 Omicron variant (B. 1.1. 529) has been recognized as a
severe threat despite many countries' best attempts to limit the so-called COVID-19 …
severe threat despite many countries' best attempts to limit the so-called COVID-19 …
Targeting SARS-CoV-2 and host cell receptor interactions
SP Lim - Antiviral Research, 2023 - Elsevier
Despite the availability of vaccines and therapeutics, continual genetic alterations render the
severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) a persistent threat …
severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) a persistent threat …
[HTML][HTML] SARS-CoV-2 variants of concerns in animals: An unmonitored rising health threat
ARA Saied, AA Metwally - Virusdisease, 2022 - Springer
Recent findings have highlighted the urgency for rapidly detecting and characterizing SARS-
CoV-2 variants of concern in companion and wild animals. The significance of active …
CoV-2 variants of concern in companion and wild animals. The significance of active …
Immunomodulatory approaches in managing lung inflammation in COVID‐19: a double‐edge sword
Introduction The novel coronavirus infectious disease 2019 (COVID‐19) which is caused by
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has emerged as a gigantic …
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has emerged as a gigantic …
Deltacron: Apprehending a new phase of the COVID-19 pandemic
The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) was initially detected in late 2019, and it has …
syndrome coronavirus 2 (SARS-CoV-2) was initially detected in late 2019, and it has …
Nanobodies as a powerful platform for biomedicine
Nanobodies are small monomeric binding modules derived from camelid heavy-chain-only
antibodies. Despite lacking a light chain, nanobodies retain unimpaired binding ability. A …
antibodies. Despite lacking a light chain, nanobodies retain unimpaired binding ability. A …